EDGAR Filing Documents for 0001964306-23-000112

Form 144 - Report of proposed sale of securities:

SEC Accession No. 0001964306-23-000112

Filing Date

2023-06-29

Accepted

2023-06-29 14:08:34

Documents

Document Format Files

Seq	Description	Document	Type	Size
1		primary_doc.html	144
1		primary_doc.xml	144	4148
	Complete submission text file	0001964306-23-000112.txt		5514

Mailing Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080

Business Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 457-2700

Allogene Therapeutics, Inc. (Subject) CIK: 0001737287 (see all company filings)

IRS No.: 823562771 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-38693 | Film No.: 231056492
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ALLOGENE THERAPEUTICS, INC. 210 E. GRAND AVENUE SOUTH SAN FRANCISCO CA 94080

Business Address

Bhavnagri Veer (Reporting) CIK: 0001808980 (see all company filings)

Type: 144